Semnur Pharmaceuticals, Inc.
SMNR
$9.00
-$10.00-52.63%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -3.74M | -3.85M | -4.69M | -4.58M | -4.47M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 500.00K | 573.00K | 660.00K | 698.50K | 737.00K |
| Change in Net Operating Assets | 1.28M | 145.00K | -861.00K | -504.50K | -148.00K |
| Cash from Operations | -1.96M | -3.13M | -4.89M | -4.39M | -3.88M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 10.34M | 9.94M | 10.87M | 7.38M | 3.88M |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -8.34M | -6.82M | -5.98M | -2.99M | -- |
| Cash from Financing | 2.00M | 3.12M | 4.89M | 4.39M | 3.88M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 40.00K | -10.00K | 0.00 | -2.00K | -4.00K |